125 related articles for article (PubMed ID: 25696744)
1. Beta blockade in neurocardiogenic dysfunction: results of a clinical study.
Baselier MR; van den Bos AA
Neth Heart J; 2001 Oct; 9(7):275-278. PubMed ID: 25696744
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of intravenous metoprolol during positive isoproterenol tilt-table test in the choice of treatment for neurocardiogenic syncope.
Baran I; Gemici K; Ozdemir B; Saraç M; Güllülü S; Aydinlar A; Cordan J
Indian Heart J; 2003; 55(1):40-3. PubMed ID: 12760586
[TBL] [Abstract][Full Text] [Related]
3. A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test.
Ventura R; Maas R; Zeidler D; Schoder V; Nienaber CA; Schuchert A; Meinertz T
Pacing Clin Electrophysiol; 2002 May; 25(5):816-21. PubMed ID: 12049374
[TBL] [Abstract][Full Text] [Related]
4. Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope.
Sra JS; Murthy VS; Jazayeri MR; Shen YH; Troup PJ; Avitall B; Akhtar M
J Am Coll Cardiol; 1992 Feb; 19(2):402-8. PubMed ID: 1346266
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of the efficacy of metoprolol and verapamil in patients with syncope and positive head-up tilt test response.
Jhamb DK; Singh B; Sharda B; Kaul U; Goel P; Talwar KK; Wasir HS
Am Heart J; 1996 Sep; 132(3):608-11. PubMed ID: 8800032
[TBL] [Abstract][Full Text] [Related]
6. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
Sheldon R; Connolly S; Rose S; Klingenheben T; Krahn A; Morillo C; Talajic M; Ku T; Fouad-Tarazi F; Ritchie D; Koshman ML;
Circulation; 2006 Mar; 113(9):1164-70. PubMed ID: 16505178
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of propantheline bromide in neurocardiogenic syncope: pharmacodynamic implications.
Yu JC; Sung RJ
Cardiovasc Drugs Ther; 1997 Jan; 10(6):687-92. PubMed ID: 9110111
[TBL] [Abstract][Full Text] [Related]
8. Changes in plasma epinephrine concentration and in heart rate during head-up tilt testing in patients with neurocardiogenic syncope: correlation with successful therapy with beta-receptor antagonists.
Klingenheben T; Kalusche D; Li YG; Schöpperl M; Hohnloser SH
J Cardiovasc Electrophysiol; 1996 Sep; 7(9):802-8. PubMed ID: 8884509
[TBL] [Abstract][Full Text] [Related]
9. Tilt-table testing and oral metoprolol therapy in young patients with unexplained syncope.
O'Marcaigh AS; MacLellan-Tobert SG; Porter CJ
Pediatrics; 1994 Feb; 93(2):278-83. PubMed ID: 8121741
[TBL] [Abstract][Full Text] [Related]
10. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
Cox MM; Perlman BA; Mayor MR; Silberstein TA; Levin E; Pringle L; Castellanos A; Myerburg RJ
J Am Coll Cardiol; 1995 Nov; 26(5):1293-8. PubMed ID: 7594046
[TBL] [Abstract][Full Text] [Related]
11. Syncope in patients with right ventricle outflow tract premature beats and no apparent structural cardiopathy.
Ludovice AC; Hachul DT; Darrieux FC; Bastos SC; Sosa EA; Scanavacca MI
Arq Bras Cardiol; 2006 Nov; 87(5):570-4. PubMed ID: 17221031
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to beta-blockers.
Klingenheben T; Credner S; Hohnloser SH
Pacing Clin Electrophysiol; 1999 Feb; 22(2):276-81. PubMed ID: 10087541
[TBL] [Abstract][Full Text] [Related]
13. Response to beta blockers in patients with neurocardiogenic syncope: how to predict beneficial effects.
Natale A; Newby KH; Dhala A; Akhtar M; Sra J
J Cardiovasc Electrophysiol; 1996 Dec; 7(12):1154-8. PubMed ID: 8985804
[TBL] [Abstract][Full Text] [Related]
14. Significance of tilt table testing in patients with suspected arrhythmic syncope and negative electrophysiologic study.
García-Civera R; Ruiz-Granell R; Morell-Cabedo S; Sanjuan-Mañez R; Ferrero A; Martínez-Brotons A; Roselló A; Botella S; Llacer A
J Cardiovasc Electrophysiol; 2005 Sep; 16(9):938-42. PubMed ID: 16174011
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole.
Sra JS; Jazayeri MR; Avitall B; Dhala A; Deshpande S; Blanck Z; Akhtar M
N Engl J Med; 1993 Apr; 328(15):1085-90. PubMed ID: 8455666
[TBL] [Abstract][Full Text] [Related]
16. Midodrine: a role in the management of neurocardiogenic syncope.
Ward CR; Gray JC; Gilroy JJ; Kenny RA
Heart; 1998 Jan; 79(1):45-9. PubMed ID: 9505918
[TBL] [Abstract][Full Text] [Related]
17. The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
Cohen TJ; Cayenne S; Black M; Doolittle S; Ibrahim B; Quan W
J Invasive Cardiol; 1999 Jul; 11(7):457-60. PubMed ID: 10745573
[TBL] [Abstract][Full Text] [Related]
18. Absence of tachycardia during tilt test predicts failure of beta-blocker therapy in patients with neurocardiogenic syncope.
Leor J; Rotstein Z; Vered Z; Kaplinsky E; Truman S; Eldar M
Am Heart J; 1994 Jun; 127(6):1539-43. PubMed ID: 7910998
[TBL] [Abstract][Full Text] [Related]
19. Effects of age on outcome of tilt-table testing.
Bloomfield D; Maurer M; Bigger JT
Am J Cardiol; 1999 Apr; 83(7):1055-8. PubMed ID: 10190519
[TBL] [Abstract][Full Text] [Related]
20. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results.
Mahanonda N; Bhuripanyo K; Kangkagate C; Wansanit K; Kulchot B; Nademanee K; Chaithiraphan S
Am Heart J; 1995 Dec; 130(6):1250-3. PubMed ID: 7484777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
